Challenges and Potential of BTK Inhibitors in MS Treatment

Bruce Cree, MD, PhD, MAS, FAAN, the clinical research director of the UCSF Multiple Sclerosis Center, talked about results from clinical trials assessing BTK inhibitors in relapsing multiple sclerosis and the ongoing research to explore more effective treatments.
Read more: www.neurologyl...
View more CMSC content: www.neurologyl...